- Yahoo Finance
Meet innovative vaccine technology from Novavax. Our biotech company prevents a broad range of infectious diseases through recombinant nanoparticle technology.
Shareholders seeking information can contact investor relations at (240) 268-2022 or email us at email@example.com. Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.
"Although all [COVID-19] vaccines teach our immune system to recognize the spike protein on the surface of the SARS-CoV-2 virus, Novavax is unique compared to other available COVID-19 vaccines in ...
Novavax and Serum Institute of India Announce Full Product Registration in South Africa of Novavax COVID-19 Vaccine as a Primary Series for Adults Aged 18 and Older Download Sep 12, 2022
The Centers for Disease Control and Prevention signed off on Novavax's Covid-19 vaccine on Tuesday. In a statement, the CDC said the shots will be available in the coming weeks.
Novavax Inc. NVAX, +7.62% said Tuesday that one million doses of its protein-based COVID vaccine Nuvaxovid are now available in the U.K. "With U.K. data showing that people infected with both ...
Novavax Inc NVAX announced that an initial one million doses of Nuvaxovid (NVX-CoV2373) COVID-19 vaccine are now available in the U.K.; Nuvaxovid is the first protein-based COVID-19 vaccine ...
Novavax says one million doses of its COVID vaccine now available in the UK Sep. 27, 2022 at 8:33 a.m. ET by Ciara Linnane Novavax Inc. stock falls Monday, underperforms market
Novavax Pharmaceutical Manufacturing Gaithersburg, Maryland 52,662 followers Producing next-generation vaccines with global access for more people.
Novavax COVID-19 Vaccine, Adjuvanted is available under EUA to prevent COVID-19 in individuals 12 years of age and older. The vaccine is authorized for emergency use as a two-dose primary series.